Microalgae Supplement BrainPhyt Shows Promise for Cognitive Health in Older Adults
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Summary
Researchers tested BrainPhyt, a microalgae-based supplement rich in fucoxanthin, to see if it could improve cognitive function in healthy older adults. The 24-week study enrolled 66 participants who took either high-dose, low-dose, or placebo supplements daily. Scientists measured spatial working memory, attention, vigilance, episodic memory, and executive function, along with stress levels, mood, sleep quality, and blood biomarkers. Fucoxanthin is a marine carotenoid with known neuroprotective properties in laboratory studies, but this represents one of the first human trials testing its cognitive benefits. The completed study aims to determine whether natural compounds from microalgae could offer a promising approach to maintaining brain health during aging.
Detailed Summary
A completed clinical trial investigated whether BrainPhyt, a microalgae-derived supplement containing fucoxanthin, could enhance cognitive performance in healthy older adults. This research addresses the growing need for natural interventions to support brain health as populations age globally.
The 24-week randomized controlled trial enrolled 66 healthy older participants who received either high-dose BrainPhyt, low-dose BrainPhyt, or placebo (maltodextrin) daily. Researchers measured multiple cognitive domains including spatial working memory, attention and vigilance, episodic memory, and executive function. Additional assessments covered stress levels, mood, sleep quality, and various biomarkers.
Fucoxanthin, the active compound in BrainPhyt, is a carotenoid pigment found abundantly in marine microalgae. Laboratory studies have demonstrated its neuroprotective properties, but human clinical evidence has been limited. Microalgae represent an untapped resource of bioactive compounds, with marine environments harboring up to 2 million species, most unexplored for therapeutic applications.
The study ran from September 2022 to May 2023, representing one of the first human trials specifically testing fucoxanthin's cognitive benefits. While detailed results await publication, this research could establish whether microalgae-derived supplements offer a viable natural approach to cognitive health optimization. The findings may inform future dietary strategies for healthy aging and provide evidence for incorporating marine-derived compounds into longevity protocols, potentially offering an ecological alternative to synthetic cognitive enhancers.
Key Findings
- First human trial testing fucoxanthin-rich microalgae supplement for cognitive enhancement
- 24-week intervention period tested both high and low doses against placebo
- Study measured comprehensive cognitive battery including memory and executive function
- Trial completed successfully with 66 healthy older adult participants
- Research explores marine microalgae as untapped source of neuroprotective compounds
Methodology
Randomized controlled trial with 66 healthy older adults over 24 weeks. Participants received high-dose BrainPhyt, low-dose BrainPhyt, or maltodextrin placebo. Comprehensive cognitive testing battery plus biomarker analysis.
Study Limitations
Single-center study with relatively small sample size may limit generalizability. Results not yet published, preventing assessment of effect sizes or clinical significance of any observed benefits.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.